According to a prior study, dexamethasone therapy restored the inflammation caused by cholestasis, as evidenced by histological findings and a significant decrease in many inflammatory markers (TNF-α, IL-1β, and IL-6) [91]. The gene discussed is IL1B; the disease is cholestasis.